322 related articles for article (PubMed ID: 23637122)
1. Noninvasive detection of HER2 amplification with plasma DNA digital PCR.
Gevensleben H; Garcia-Murillas I; Graeser MK; Schiavon G; Osin P; Parton M; Smith IE; Ashworth A; Turner NC
Clin Cancer Res; 2013 Jun; 19(12):3276-84. PubMed ID: 23637122
[TBL] [Abstract][Full Text] [Related]
2. Determination of HER2 amplification status on tumour DNA by digital PCR.
Garcia-Murillas I; Lambros M; Turner NC
PLoS One; 2013; 8(12):e83409. PubMed ID: 24386193
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer.
Shoda K; Ichikawa D; Fujita Y; Masuda K; Hiramoto H; Hamada J; Arita T; Konishi H; Komatsu S; Shiozaki A; Kakihara N; Okamoto K; Taniguchi H; Imoto I; Otsuji E
Gastric Cancer; 2017 Jan; 20(1):126-135. PubMed ID: 26874951
[TBL] [Abstract][Full Text] [Related]
4. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples.
Ishii H; Azuma K; Sakai K; Kawahara A; Yamada K; Tokito T; Okamoto I; Nishio K; Hoshino T
Oncotarget; 2015 Oct; 6(31):30850-8. PubMed ID: 26334838
[TBL] [Abstract][Full Text] [Related]
5. Plasma HER2 amplification in cell-free DNA during neoadjuvant chemotherapy in breast cancer.
Bechmann T; Andersen RF; Pallisgaard N; Madsen JS; Maae E; Jakobsen EH; Bak Jylling AM; Steffensen KD; Jakobsen A
J Cancer Res Clin Oncol; 2013 Jun; 139(6):995-1003. PubMed ID: 23479212
[TBL] [Abstract][Full Text] [Related]
6. Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues.
Tantiwetrueangdet A; Panvichian R; Wongwaisayawan S; Sueangoen N; Lertsithichai P
Med Oncol; 2018 Oct; 35(12):149. PubMed ID: 30284063
[TBL] [Abstract][Full Text] [Related]
7. Detection of HER2 amplification in circulating free DNA in patients with breast cancer.
Page K; Hava N; Ward B; Brown J; Guttery DS; Ruangpratheep C; Blighe K; Sharma A; Walker RA; Coombes RC; Shaw JA
Br J Cancer; 2011 Apr; 104(8):1342-8. PubMed ID: 21427727
[TBL] [Abstract][Full Text] [Related]
8. Assessing HER2 Amplification in Plasma cfDNA.
Garcia-Murillas I; Turner NC
Methods Mol Biol; 2018; 1768():161-172. PubMed ID: 29717443
[TBL] [Abstract][Full Text] [Related]
9. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
[TBL] [Abstract][Full Text] [Related]
10. Detection of HER2 amplification in formalin-fixed paraffin-embedded breast carcinoma tissue with digital PCR using two TFF3 sequences as internal reference.
Yu R; Xuan W; Zhou L; Luo Y; Liu X; Xiong P; Ren X
Exp Mol Pathol; 2018 Jun; 104(3):235-238. PubMed ID: 29715436
[TBL] [Abstract][Full Text] [Related]
11. HER2 protein and gene variation between primary and metastatic breast cancer: significance and impact on patient care.
Fabi A; Di Benedetto A; Metro G; Perracchio L; Nisticò C; Di Filippo F; Ercolani C; Ferretti G; Melucci E; Buglioni S; Sperduti I; Papaldo P; Cognetti F; Mottolese M
Clin Cancer Res; 2011 Apr; 17(7):2055-64. PubMed ID: 21307144
[TBL] [Abstract][Full Text] [Related]
12. Plasma HER2 (
Siravegna G; Sartore-Bianchi A; Nagy RJ; Raghav K; Odegaard JI; Lanman RB; Trusolino L; Marsoni S; Siena S; Bardelli A
Clin Cancer Res; 2019 May; 25(10):3046-3053. PubMed ID: 30808777
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features of breast cancer reclassified as HER2-amplified by fluorescence in situ hybridization with alternative chromosome 17 probes.
Blanton KC; Deal AM; Kaiser-Rogers KA; Anders CK; O'Connor SM; Hertel JD; Calhoun BC
Ann Diagn Pathol; 2020 Oct; 48():151576. PubMed ID: 32805517
[TBL] [Abstract][Full Text] [Related]
14. Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis.
Wang Y; Tsang JYS; Cui Y; Cui J; Lin Y; Zhao S; Law PTW; Cheung SY; Ng EKO; Tse GMK; Ke Z
Sci Rep; 2017 Jul; 7(1):6752. PubMed ID: 28754904
[TBL] [Abstract][Full Text] [Related]
15. Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers.
Lamy PJ; Fina F; Bascoul-Mollevi C; Laberenne AC; Martin PM; Ouafik L; Jacot W
Breast Cancer Res; 2011 Feb; 13(1):R15. PubMed ID: 21288332
[TBL] [Abstract][Full Text] [Related]
16. Determining true HER2 gene status in breast cancers with polysomy by using alternative chromosome 17 reference genes: implications for anti-HER2 targeted therapy.
Tse CH; Hwang HC; Goldstein LC; Kandalaft PL; Wiley JC; Kussick SJ; Gown AM
J Clin Oncol; 2011 Nov; 29(31):4168-74. PubMed ID: 21947821
[TBL] [Abstract][Full Text] [Related]
17. HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study.
Shoda K; Masuda K; Ichikawa D; Arita T; Miyakami Y; Watanabe M; Konishi H; Imoto I; Otsuji E
Gastric Cancer; 2015 Oct; 18(4):698-710. PubMed ID: 25322965
[TBL] [Abstract][Full Text] [Related]
18. Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer.
Varga Z; Tubbs RR; Wang Z; Sun Y; Noske A; Kradolfer D; Bosshard G; Jochum W; Moch H; Öhlschlegel C
Breast Cancer Res Treat; 2012 Apr; 132(3):925-35. PubMed ID: 21698407
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer.
Guan X; Liu B; Niu Y; Dong X; Zhu X; Li C; Li L; Yi Z; Sun X; Chen H; Lu S; Ma F
Breast; 2020 Feb; 49():261-266. PubMed ID: 31927339
[TBL] [Abstract][Full Text] [Related]
20. HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer.
Takegawa N; Yonesaka K; Sakai K; Ueda H; Watanabe S; Nonagase Y; Okuno T; Takeda M; Maenishi O; Tsurutani J; Satoh T; Okamoto I; Nishio K; Tamura T; Nakagawa K
Oncotarget; 2016 Jan; 7(3):3453-60. PubMed ID: 26657506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
